PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 79 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $159,000 | +1666.7% | 437,513 | +2023.7% | 0.00% | – |
| Q1 2016 | $9,000 | -82.4% | 20,601 | -53.1% | 0.00% | – |
| Q4 2015 | $51,000 | -26.1% | 43,948 | -35.0% | 0.00% | – |
| Q3 2015 | $69,000 | -16.9% | 67,634 | +7.7% | 0.00% | – |
| Q2 2015 | $83,000 | +93.0% | 62,782 | +98.0% | 0.00% | – |
| Q1 2015 | $43,000 | -29.5% | 31,716 | -28.2% | 0.00% | – |
| Q4 2014 | $61,000 | +13.0% | 44,145 | +12.4% | 0.00% | – |
| Q3 2014 | $54,000 | -64.9% | 39,261 | -52.3% | 0.00% | – |
| Q2 2014 | $154,000 | -37.9% | 82,226 | -36.9% | 0.00% | – |
| Q1 2014 | $248,000 | +28.5% | 130,391 | -6.5% | 0.00% | – |
| Q4 2013 | $193,000 | +13.5% | 139,517 | +14.5% | 0.00% | – |
| Q3 2013 | $170,000 | +75.3% | 121,801 | +61.5% | 0.00% | – |
| Q2 2013 | $97,000 | -44.9% | 75,425 | -42.8% | 0.00% | – |
| Q1 2013 | $176,000 | – | 131,899 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delaney Dennis R | 60,000 | $25,000 | 0.05% |
| Freedom Investment Management, Inc. | 1,422,314 | $597,000 | 0.04% |
| Sterling Global Strategies LLC | 10,000 | $4,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,009,400 | $424,000 | 0.01% |
| CORRADO ADVISORS, LLC | 15,000 | $6,000 | 0.00% |
| First Heartland Consultants, Inc. | 17,240 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 37,955 | $16,000 | 0.00% |
| Commonwealth Equity Services, Inc | 486,961 | $205,000 | 0.00% |
| QS Investors, LLC | 503,400 | $212,000 | 0.00% |
| Perceptive Advisors | 24,332 | $10,000 | 0.00% |